(Q53803725)

19 May 2018

title

Volume factor in low and normal renin essential hypertension. Treatment with either spironolactone or chlorthalidone. (English)

1 reference

19 May 2018

main subject

arterial hypertension

0 references

author name string

Vaughan ED Jr

1

1 reference

19 May 2018

Laragh JH

2

1 reference

19 May 2018

Gavras I

3

1 reference

19 May 2018

Bühler FR

4

1 reference

19 May 2018

Gavras H

5

1 reference

19 May 2018

Brunner HR

6

1 reference

19 May 2018

Baer L

7

1 reference

19 May 2018

language of work or name

English

0 references

publication date

1 September 1973

1 reference

19 May 2018

American Journal of Cardiology

published in

1 reference

19 May 2018

volume

32

1 reference

19 May 2018

issue

4

1 reference

19 May 2018

page(s)

523-532

1 reference

19 May 2018

Essential hypertension: renin and aldosterone, heart attack and stroke.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980044-X

Renin, angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980044-X

Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980044-X

Effect of Spironolactone in Hypertensive Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980044-X

Hypertension and Low Plasma Renin Activity: Presumptive Evidence for Mineralocorticoid Excess

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980044-X

Hyporeninemic hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980044-X

The syndrome of essential hypertension and suppressed plasma renin activity. Normalization of blood pressure with spironolactone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980044-X

Apparently isolated excess deoxycorticosterone in hypertension. A variant of the mineralocorticoid-excess syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980044-X

Suppressed plasma renin activity in essential hypertension. Roles of plasma volume, blood pressure, and sympathetic nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980044-X

Metabolic Studies on Hypertensive Patients with Suppressed Plasma Renin Activity Not Due to Hyperaldosteronism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980044-X

Vasoconstriction-volume analysis for understanding and treating hypertension: the use of renin and aldosterone profiles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980044-X

The control of aldosterone secretion in normal and hypertensive man: abnormal renin-aldosterone patterns in low renin hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980044-X

The renin system: Variations in man measured by radioimmunoassay or bioassay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980044-X

Aldosterone excretion. Physiological variations in man measured by radioimmunoassay or double-isotope dilution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980044-X

Potassium balance and the control of renin secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980044-X

The influence of potassium administration and of potassium deprivation on plasma renin in normal and hypertensive subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980044-X

Spironolactone and hydrochlorothiazide in essential hypertension. Blood pressure response and plasma renin activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980044-X

The effects of spironolactone and chlorthalidone on arterial pressure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980044-X

Treatment of arterial hypertensive disease with diuretics. V. Spironolactone, an aldosterone antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980044-X

Comparative Studies on Spironolactone (Aldactone) and Chlorthalidone (Hygroton) in the Treatment of Arterial Hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980044-X

Relationship between plasma and extracellular fluid volume depletion and the antihypertensive effect of chlorothiazide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980044-X

Changes in Plasma and Extracellular Fluid Volumes in Patients with Essential Hypertension During Long-Term Treatment with Hydrochlorothiazide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980044-X

Long-term thiazide therapy in essential hypertension. Evidence for persistent alteration in plasma volume and renin activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980044-X

Why Do Thiazide Diuretics Lower Blood Pressure in Essential Hypertension?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980044-X

Mechanism of the altered blood pressure responsiveness produced by chlorothiazide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980044-X

Effect of chlorothiazide and sodium on vascular responsiveness to angiotensin II

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980044-X

Chlorothiazide in hypertension: studies on its mode of action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980044-X

Hemodynamic and hypotensive effects of long-term therapy with chlorothiazide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980044-X

Effect of thiazide diuretics on plasma volume, body electrolytes, and excretion of aldosterone in hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980044-X

Renin-angiotensin-aldosterone system during chronic thiazide therapy of benign hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980044-X

PROLONGED INFUSIONS OF ANGIOTENSIN II AND NOREPINEPHRINE AND BLOOD PRESSURE, ELECTROLYTE BALANCE, AND ALDOSTERONE AND CORTISOL SECRETION IN NORMAL MAN AND IN CIRRHOSIS WITH ASCITES.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980044-X

Angiotensin II vascular receptors: their avidity in relationship to sodium balance, the autonomic nervous system, and hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980044-X

Antihypertensive action of propranolol. Specific antirenin responses in high and normal renin forms of essential, renal, renovascular and malignant hypertension.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980044-X

10.1016/S0002-9149(73)80044-X

7 January 2021

Identifiers

DOI

1 reference

19 May 2018

1 reference

19 May 2018